Press "Enter" to skip to content

Aurobindo Pharma gets USFDA nod for anaesthesia drug

The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Vecuronium Bromide Injection in the strengths of 10mg and 20mg, Aurobindo Pharma said in a BSE filing.

Original source:

Also Read:   UK fears crisis as 11.5 million get potentially addictive drugs